117 related articles for article (PubMed ID: 10725117)
1. Characterization of the major DNA adduct formed by alpha-hydroxy-N-desmethyltamoxifen in vitro and in vivo.
Gamboa da Costa G; Hamilton LP; Beland FA; Marques MM
Chem Res Toxicol; 2000 Mar; 13(3):200-7. PubMed ID: 10725117
[TBL] [Abstract][Full Text] [Related]
2. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.
Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR
Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and investigation of alpha-hydroxy-N,N-didesmethyltamoxifen as a proximate carcinogen in the metabolic activation of tamoxifen.
Gamboa da Costa G; Marques MM; Freeman JP; Beland FA
Chem Res Toxicol; 2003 Sep; 16(9):1090-8. PubMed ID: 12971796
[TBL] [Abstract][Full Text] [Related]
4. Further characterization of the DNA adducts formed in rat liver after the administration of tamoxifen, N-desmethyltamoxifen or N, N-didesmethyltamoxifen.
Brown K; Heydon RT; Jukes R; White IN; Martin EA
Carcinogenesis; 1999 Oct; 20(10):2011-6. PubMed ID: 10506118
[TBL] [Abstract][Full Text] [Related]
5. DNA adduct formation and mutant induction in Sprague-Dawley rats treated with tamoxifen and its derivatives.
Gamboa da Costa G; McDaniel-Hamilton LP; Heflich RH; Marques MM; Beland FA
Carcinogenesis; 2001 Aug; 22(8):1307-15. PubMed ID: 11470763
[TBL] [Abstract][Full Text] [Related]
6. Identification of the major tamoxifen-DNA adducts in rat liver by mass spectroscopy.
Rajaniemi H; Rasanen I; Koivisto P; Peltonen K; Hemminki K
Carcinogenesis; 1999 Feb; 20(2):305-9. PubMed ID: 10069469
[TBL] [Abstract][Full Text] [Related]
7. Identification of tamoxifen-DNA adducts induced by alpha-acetoxy-N-desmethyltamoxifen.
Kitagawa M; Ravindernath A; Suzuki N; Rieger R; Terashima I; Umemoto A; Shibutani S
Chem Res Toxicol; 2000 Aug; 13(8):761-9. PubMed ID: 10956064
[TBL] [Abstract][Full Text] [Related]
8. Stereoselective metabolic activation of alpha-hydroxy-N-desmethyltamoxifen: the R-isomer forms more DNA adducts in rat liver cells.
Osborne MR; Hewer A; Phillips DH
Chem Res Toxicol; 2004 May; 17(5):697-701. PubMed ID: 15144227
[TBL] [Abstract][Full Text] [Related]
9. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene.
Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM
Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033
[TBL] [Abstract][Full Text] [Related]
10. Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans.
Beland FA; Churchwell MI; Doerge DR; Parkin DR; Malejka-Giganti D; Hewer A; Phillips DH; Carmichael PL; Gamboa da Costa G; Marques MM
J Natl Cancer Inst; 2004 Jul; 96(14):1099-104. PubMed ID: 15265972
[TBL] [Abstract][Full Text] [Related]
11. Identification of the major tamoxifen-deoxyguanosine adduct formed in the liver DNA of rats treated with tamoxifen.
Osborne MR; Hewer A; Hardcastle IR; Carmichael PL; Phillips DH
Cancer Res; 1996 Jan; 56(1):66-71. PubMed ID: 8548777
[TBL] [Abstract][Full Text] [Related]
12. Hepatic DNA adduct dosimetry in rats fed tamoxifen: a comparison of methods.
Schild LJ; Phillips DH; Osborne MR; Hewer A; Beland FA; Churchwell MI; Brown K; Gaskell M; Wright E; Poirier MC
Mutagenesis; 2005 Mar; 20(2):115-24. PubMed ID: 15755801
[TBL] [Abstract][Full Text] [Related]
13. Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen.
Gamboa da Costa G; Marques MM; Fu X; Churchwell MI; Wang YP; Doerge DR; Beland FA
Cancer Lett; 2007 Nov; 257(2):191-8. PubMed ID: 17765393
[TBL] [Abstract][Full Text] [Related]
14. Formation of tamoxifen-DNA adducts in multiple organs of adult female cynomolgus monkeys dosed with tamoxifen for 30 days.
Schild LJ; Divi RL; Beland FA; Churchwell MI; Doerge DR; Gamboa da Costa G; Marques MM; Poirier MC
Cancer Res; 2003 Sep; 63(18):5999-6003. PubMed ID: 14522927
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
[TBL] [Abstract][Full Text] [Related]
16. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen.
Pathak DN; Pongracz K; Bodell WJ
Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794
[TBL] [Abstract][Full Text] [Related]
17. Organ specificity of DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen in the rat: implications for understanding the mechanism(s) of tamoxifen carcinogenicity and for human risk assessment.
Phillips DH; Hewer A; Osborne MR; Cole KJ; Churchill C; Arlt VM
Mutagenesis; 2005 Jul; 20(4):297-303. PubMed ID: 15928012
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the DNA adducts formed by tamoxifen and 4-hydroxytamoxifen in vivo.
Beland FA; McDaniel LP; Marques MM
Carcinogenesis; 1999 Mar; 20(3):471-7. PubMed ID: 10190564
[TBL] [Abstract][Full Text] [Related]
19. Identification of tamoxifen-DNA adducts formed by 4-hydroxytamoxifen quinone methide.
Marques MM; Beland FA
Carcinogenesis; 1997 Oct; 18(10):1949-54. PubMed ID: 9364005
[TBL] [Abstract][Full Text] [Related]
20. DNA adduct formation by tamoxifen and structurally-related compounds in rat liver.
Rajaniemi H; Mäntylä E; Hemminki K
Chem Biol Interact; 1998 May; 113(2):145-59. PubMed ID: 9717515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]